Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression. - Peng, Xiao-Mei; Shi, Xin-Peng; Chen, Han; Cao, Lu-Yang; Zuo, Hao-Jian; Guo, Jie-Qiong; Jiang, Nan; Luo, Xiao-Yong (Cellular Oncology (2211-3428), 2026)